Dr. Li on Preoperative Immunotherapy in Hepatocellular Carcinoma
February 6th 2019
Daneng Li, MD, an assistant clinical professor in the Department of Medical Oncology and Therapeutics Research, and a medical oncologist at City of Hope, discusses an ongoing study of preoperative immunotherapy in patients with hepatocellular carcinoma (HCC).